Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2008 4
2009 1
2010 3
2011 1
2012 3
2013 3
2014 6
2015 6
2016 6
2017 12
2018 13
2019 11
2020 20
2021 21
2022 38
2023 21
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Deodhar A, Van den Bosch F, Poddubnyy D, Maksymowych WP, van der Heijde D, Kim TH, Kishimoto M, Blanco R, Duan Y, Li Y, Pangan AL, Wung P, Song IH. Deodhar A, et al. Among authors: duan y. Lancet. 2022 Jul 30;400(10349):369-379. doi: 10.1016/S0140-6736(22)01212-0. Lancet. 2022. PMID: 35908570 Clinical Trial.
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension.
van der Heijde D, Deodhar A, Maksymowych WP, Sieper J, Van den Bosch F, Kim TH, Kishimoto M, Östör AJ, Combe B, Sui Y, Duan Y, Wung PK, Song IH. van der Heijde D, et al. Among authors: duan y. RMD Open. 2022 Jul;8(2):e002280. doi: 10.1136/rmdopen-2022-002280. RMD Open. 2022. PMID: 35896281 Free PMC article. Clinical Trial.
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study.
McInnes IB, Kato K, Magrey M, Merola JF, Kishimoto M, Pacheco-Tena C, Haaland D, Chen L, Duan Y, Zueger P, Liu J, Lippe R, Pangan AL, Behrens F. McInnes IB, et al. Among authors: duan y. RMD Open. 2021 Oct;7(3):e001838. doi: 10.1136/rmdopen-2021-001838. RMD Open. 2021. PMID: 34663636 Free PMC article. Clinical Trial.
High-throughput functional dissection of noncoding SNPs with biased allelic enhancer activity for insulin resistance-relevant phenotypes.
Duan YY, Chen XF, Zhu RJ, Jia YY, Huang XT, Zhang M, Yang N, Dong SS, Zeng M, Feng Z, Zhu DL, Wu H, Jiang F, Shi W, Hu WX, Ke X, Chen H, Liu Y, Jing RH, Guo Y, Li M, Yang TL. Duan YY, et al. Am J Hum Genet. 2023 Aug 3;110(8):1266-1288. doi: 10.1016/j.ajhg.2023.07.002. Epub 2023 Jul 27. Am J Hum Genet. 2023. PMID: 37506691 Free PMC article.
Development of a Chinese werewolf deception database.
Yang C, You X, Xie X, Duan Y, Wang B, Zhou Y, Feng H, Wang W, Fan L, Huang G, Shen X. Yang C, et al. Among authors: duan y. Front Psychol. 2023 Jan 9;13:1047427. doi: 10.3389/fpsyg.2022.1047427. eCollection 2022. Front Psychol. 2023. PMID: 36698609 Free PMC article.
Dynamics of Skin Mycobiome in Infants.
Zhu T, Duan YY, Kong FQ, Galzote C, Quan ZX. Zhu T, et al. Front Microbiol. 2020 Jul 28;11:1790. doi: 10.3389/fmicb.2020.01790. eCollection 2020. Front Microbiol. 2020. PMID: 32849406 Free PMC article.
159 results